David Stover
Fondateur chez Nammi Therapeutics, Inc.
Profil
David Stover is the founder of Nammi Therapeutics, Inc. He is currently a Director at Meditope Biosciences, Inc. He was previously a Senior VP & Head-Research at Agensys, Inc. He received his undergraduate degree from Duke University and his doctorate from the University of Washington.
Postes actifs de David Stover
| Sociétés | Poste | Début |
|---|---|---|
Meditope Biosciences, Inc.
 Meditope Biosciences, Inc. BiotechnologyHealth Technology Meditope Biosciences, Inc. develops antibody-based cancer therapeutics. The private company is based in Pasadena, CA. | Directeur/Membre du Conseil | 10/07/2018 |
Nammi Therapeutics, Inc.
 Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de David Stover
| Sociétés | Poste | Fin |
|---|---|---|
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de David Stover
| University of Washington | Doctorate Degree |
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Meditope Biosciences, Inc.
Meditope Biosciences, Inc. BiotechnologyHealth Technology Meditope Biosciences, Inc. develops antibody-based cancer therapeutics. The private company is based in Pasadena, CA. | Health Technology |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Health Technology |
